American Brivision (holding) Revenue Growth Rates (ABVCD), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
American Brivision (holding) Corp  (ABVCD)
 

ABVCD's Revenue Growth by Quarter and Year

American Brivision (holding)'s Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABVCD Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 0.21
FY 0.21





ABVCD Revenue first quarter 2019 Y/Y Growth Comment
American Brivision (holding) Corp in the first quarter 2019 achieved Revenue of $ 0.21 millions compare to recorded in same quarter a year ago.

According to the results reported in the first quarter 2019, American Brivision (holding) Corp achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While American Brivision (holding) Corp' s Revenue no change of 0% ranks overall at the positon no. in the first quarter 2019.


ABVCD Revenue ( Y/Y Growth %) 2019
 2018 2017 2016
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   - - - -

Financial Statements
American Brivision (holding)'s first quarter 2019 Revenue $ 0.21 millions ABVCD's Income Statement
American Brivision (holding)'s first quarter 2018 Revenue $ 0.00 millions Quarterly ABVCD's Income Statement


ABVCD Revenue (Quarter on Quarter Growth %)

 2019
 2018 2017 2016
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   - - - -


Back to ABVCD Growth rate Comparisons >> Back to ABVCD Growth rate Comparisons >>


Revenue first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

American Brivision (holding)'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ABVCD's I. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ABVCD's I. Quarter Q/Q Revenue Comment


American Brivision (holding)'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2019)		 12 Months Ending
 12 Months Ending
 12 Months Ending
 12 Months Ending
Cumulative Revenue 12 Months Ending $ 0.21 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment


American Brivision (holding) Corp achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment


American Brivision (holding) Corp achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ABVCD's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending Mar 31 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2019
Surgery Partners Inc -0.14%$ -0.136 millions
Luminex Corporation-0.31%$ -0.307 millions
Hutchmed china Limited-0.32%$ -0.323 millions
Sonida Senior Living Inc -0.41%$ -0.407 millions
Ironwood Pharmaceuticals inc -0.61%$ -0.615 millions
Becton Dickinson And Company-0.64%$ -0.640 millions
Elanco Animal Health Incorporated-0.69%$ -0.693 millions
Alkermes Plc -0.91%$ -0.910 millions
Dentsply Sirona Inc -1.04%$ -1.035 millions
Abbvie Inc -1.34%$ -1.336 millions
Utah Medical Products Inc-1.42%$ -1.424 millions
American Renal Associates Holdings Inc -1.49%$ -1.495 millions
Phibro Animal Health Corporation-1.52%$ -1.518 millions
Sorrento Therapeutics Inc -1.65%$ -1.649 millions
Catalent Inc -1.66%$ -1.656 millions
Baxter International Inc -1.68%$ -1.681 millions
Allied Healthcare Products inc -1.78%$ -1.781 millions
Jounce Therapeutics inc -1.79%$ -1.786 millions
Envista Holdings Corporation-1.92%$ -1.918 millions
Labcorp Holdings Inc -2.00%$ -2.005 millions
Allergan plc-2.04%$ -2.042 millions
Zimmer Biomet Holdings Inc -2.09%$ -2.087 millions
Arvinas Inc -2.24%$ -2.242 millions
Elite Health Systems Inc -2.77%$ -2.775 millions
Waters Corporation-3.17%$ -3.167 millions
Procyon Corporation-3.27%$ -3.269 millions
Tenet Healthcare Corp-3.28%$ -3.277 millions
Cellular Biomedicine Group Inc -3.33%$ -3.328 millions
Enveric Biosciences Inc -3.41%$ -3.406 millions
Perrigo Company Plc-3.49%$ -3.492 millions


About American Brivision (holding) Revenue Growth Rates (ABVCD), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Abvc Biopharma Inc (CIK 1173313).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001213900-26-088348
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Abvc Biopharma Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.